Stay updated on CD19/CD20/CD22 Triple-targeted Cell Clinical Trial
Sign up to get notified when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.

Latest updates to the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page
- Check7 days agoChange DetectedA new revision entry (v3.6.3) has been added to the study history, and the previous revision (v3.6.2) has been removed. This represents an update to the record's version history.SummaryDifference0.1%

- Check14 days agoChange DetectedAdded Revision: v3.6.2 to the study record history, reflecting a software update to the page's revision tracking. This update marks the latest version label in the history table.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe study record now indicates that the trial is no longer looking for participants, signaling that enrollment has been halted. This update also accompanies a revision label of v3.6.0, replacing the prior v3.5.5.SummaryDifference0.7%

- Check36 days agoChange DetectedThe record history shows a new latest revision labeled v3.5.5, superseding the previous v3.5.4, reflecting an update to the page's historical metadata.SummaryDifference0.1%

- Check57 days agoChange DetectedNew revision entry added: 'Revision: v3.5.4'. The previous revision 'Revision: v3.5.3' is removed, indicating an updated release note for the record history.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page’s interface revision number has been updated from version v3.5.2 to v3.5.3, reflecting a site software/release update rather than a modification to the trial record.SummaryDifference0.1%

Stay in the know with updates to CD19/CD20/CD22 Triple-targeted Cell Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.